CN1301258A - 苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用 - Google Patents

苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用 Download PDF

Info

Publication number
CN1301258A
CN1301258A CN99806421A CN99806421A CN1301258A CN 1301258 A CN1301258 A CN 1301258A CN 99806421 A CN99806421 A CN 99806421A CN 99806421 A CN99806421 A CN 99806421A CN 1301258 A CN1301258 A CN 1301258A
Authority
CN
China
Prior art keywords
compound
benzo
furoxane
benzo furoxane
logical formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99806421A
Other languages
English (en)
Chinese (zh)
Inventor
A·桑卡兰拉亚那
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrent Pharmaceuticals Ltd
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of CN1301258A publication Critical patent/CN1301258A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CN99806421A 1998-05-22 1999-05-17 苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用 Pending CN1301258A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (enExample) 1998-05-22 1998-05-22
IN935/CAL/1998 1998-05-22

Publications (1)

Publication Number Publication Date
CN1301258A true CN1301258A (zh) 2001-06-27

Family

ID=11085434

Family Applications (2)

Application Number Title Priority Date Filing Date
CN99806421A Pending CN1301258A (zh) 1998-05-22 1999-05-17 苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用
CN99806440A Pending CN1302205A (zh) 1998-05-22 1999-05-17 苯并n－氧化噁二唑衍生物在治疗心绞痛中的应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN99806440A Pending CN1302205A (zh) 1998-05-22 1999-05-17 苯并n－氧化噁二唑衍生物在治疗心绞痛中的应用

Country Status (16)

Country Link
US (2) US6248895B1 (enExample)
EP (2) EP1079829B1 (enExample)
JP (2) JP2002516275A (enExample)
CN (2) CN1301258A (enExample)
AT (2) ATE245419T1 (enExample)
AU (2) AU3623299A (enExample)
BR (2) BR9910628A (enExample)
CA (2) CA2333001A1 (enExample)
CZ (1) CZ20004072A3 (enExample)
DE (2) DE69918431T2 (enExample)
ES (1) ES2222029T3 (enExample)
HU (2) HUP0102057A3 (enExample)
IN (1) IN188837B (enExample)
PT (1) PT1080081E (enExample)
RU (2) RU2222532C2 (enExample)
WO (2) WO1999061018A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592145A (zh) * 2015-01-15 2015-05-06 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
WO2003053439A1 (en) * 2001-12-20 2003-07-03 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
DE60302454T2 (de) 2002-04-19 2006-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonisten-verbindungen mit stickoxid-donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
WO2004050084A2 (en) * 2002-11-29 2004-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and nitricoxid-donor activity
TWI383975B (zh) * 2004-03-31 2013-02-01 悌柏泰克醫藥有限公司 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
US7093310B2 (en) * 2005-01-03 2006-08-22 Miranda Industries, Inc. Beddress
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN101270068B (zh) * 2008-04-23 2011-05-18 常州亚邦齐晖医药化工有限公司 一种2-硝基-4-丙硫基苯胺的制备方法
CA2761288C (en) * 2008-07-02 2017-09-05 The University Of Queensland Pain-relieving compositions of furoxan no donors and uses thereof
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
BE794742A (fr) * 1972-02-01 1973-07-30 Bayer Ag Nouveaux di-n-oxydes (1,4) de benzo-1,2,4-triazine, leur procede de preparation et leur application comme medicaments et additifs de nutrition
US4014893A (en) * 1973-05-11 1977-03-29 Imperial Chemical Industries Limited 3,4-Cycloalkano furoxans
US4185018A (en) * 1978-08-21 1980-01-22 Ciba-Geigy Corporation Process for producing benzofurazan-1-oxides
US4544400A (en) * 1982-02-22 1985-10-01 Zoecon Corporation Compositions
JPS6072874A (ja) * 1983-09-28 1985-04-24 Kazuhiro Imai ２，１，３−ベンゾオキサジアゾ−ルの新規誘導体
JPS6383078A (ja) * 1986-09-25 1988-04-13 Honsyu Kagaku Kogyo Kk ベンゾフラザン−１−オキシドの製造方法
US5272164A (en) 1988-12-27 1993-12-21 Kirin Beer Kabushiki Kaisha Carboximidamide derivatives
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
RU2032678C1 (ru) * 1991-06-28 1995-04-10 Институт органической и физической химии им.А.Е.Арбузова Казанского филиала РАН 4- или 6-нитро-5,7-дихлорбензофуроксан, обладающий фунгицидной активностью
RU2076803C1 (ru) * 1992-04-22 1997-04-10 Институт органической и физической химии им.А.Е.Арбузова Казанского филиала РАН Фунгицидный состав
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4220264A1 (de) 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
US5659095A (en) * 1996-03-13 1997-08-19 Uniroyal Chemical Company, Inc. Composition for inhibiting the polymerization of aromatic vinyl monomers
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592145A (zh) * 2015-01-15 2015-05-06 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用
WO2016112768A1 (zh) * 2015-01-15 2016-07-21 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Also Published As

Publication number Publication date
CN1302205A (zh) 2001-07-04
EP1079829B1 (en) 2003-07-23
DE69918431T2 (de) 2005-07-14
RU2209065C2 (ru) 2003-07-27
CZ20004072A3 (cs) 2001-08-15
JP2002516275A (ja) 2002-06-04
ATE270279T1 (de) 2004-07-15
WO1999061018A1 (en) 1999-12-02
DE69909782D1 (de) 2003-08-28
AU3623299A (en) 1999-12-13
EP1080081B1 (en) 2004-06-30
EP1080081A1 (en) 2001-03-07
JP3378239B2 (ja) 2003-02-17
US6232331B1 (en) 2001-05-15
HUP0101584A2 (hu) 2001-11-28
US6248895B1 (en) 2001-06-19
ATE245419T1 (de) 2003-08-15
PT1080081E (pt) 2004-10-29
WO1999061430A1 (en) 1999-12-02
JP2002516317A (ja) 2002-06-04
BR9910628A (pt) 2001-01-30
ES2222029T3 (es) 2005-01-16
CA2333001A1 (en) 1999-12-02
HUP0102057A3 (en) 2002-12-28
DE69918431D1 (de) 2004-08-05
IN188837B (enExample) 2002-11-09
CA2332950A1 (en) 1999-12-02
AU3623399A (en) 1999-12-13
RU2222532C2 (ru) 2004-01-27
EP1079829A1 (en) 2001-03-07
HUP0102057A2 (hu) 2001-11-28
HUP0101584A3 (en) 2002-12-28
BR9910637A (pt) 2001-02-06

Similar Documents

Publication Publication Date Title
EP1499589B1 (fr) Derives de n-¬phenyl(piperidin-2-yl)methyl|benzamide, leur preparation et leur application en therapeutique
CN1189170C (zh) 噻吩基唑基烷氧基乙胺,它们的制备以及它们作为药物的应用
CN1187188A (zh) 旋转异构酶活性的小分子抑制剂
CN1301258A (zh) 苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用
EP2430012A1 (fr) Dérivés de 7-aza-spiro[3.5]nonane-7-carboxylates, leur prépraration et leur application en thérapeutique
CN1176080C (zh) 茚并一,萘并一和苯并环庚二氢噻唑衍生物,它们的制备以及它们作为降低食欲药的用途
CN1289481C (zh) 作为降低脂质剂的联苯甲酰胺化合物
FR2786179A1 (fr) Composes quaternaires de piperidine antagonistes du recepteur ccr-3, composition pharmaceutique les contenant, leur utilisation et leur preparation
FR2934265A1 (fr) Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
FR2866885A1 (fr) Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
CN1340044A (zh) 莫维诺林衍生物
WO2005077898A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
CN1250536C (zh) 4－氨基苯并吡喃衍生物
CN1104017A (zh) 取代的(芳烷氧基苄基)氨基丙酰胺衍生物及其制备方法
CN1255131A (zh) 作为氧化氮合酶抑制剂的脒衍生物
CN1121713A (zh) 丝氨酸衍生物
CN1094126C (zh) 吡咯并吖庚因化合物
CN100349881C (zh) 取代五元氮杂环盐类化合物及其治疗蛋白老化相关疾病的用途
EP2185525B1 (fr) Dérivés de pyrazole 3,5-carboxylates, leur préparation et leur application en thérapeutique
EP1773823B1 (fr) Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
EP1270562B1 (fr) Nouveaux dérivés cycliques d'alpha-amino-gamma-hydroxy-amides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN1150420A (zh) 4-喹啉酮衍生物及其盐
WO1995031449A1 (fr) Nouveaux esters de 3,5-dimethylpiperidin-1-ylalkyle
HK1025948B (en) Anti-inflammatory compounds
HK1025948A1 (en) Anti-inflammatory compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication